These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6148516)

  • 1. Treatment of advanced myelodysplastic syndrome with alfacalcidol.
    Mehta AB; Kumaran TO; Marsh GW; McCarthy DM
    Lancet; 1984 Sep; 2(8405):761. PubMed ID: 6148516
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 (1 alpha(OH)D3)].
    Taoka T; Hamamoto T; Okuda Y; Hata Y; Kubota Y; Tanaka T; Irino S; Miyazaki T; Ohbayashi S
    Rinsho Ketsueki; 1987 Jun; 28(6):830-8. PubMed ID: 3478504
    [No Abstract]   [Full Text] [Related]  

  • 3. G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.
    Becker PS; Medeiros BC; Stein AS; Othus M; Appelbaum FR; Forman SJ; Scott BL; Hendrie PC; Gardner KM; Pagel JM; Walter RB; Parks C; Wood BL; Abkowitz JL; Estey EH
    Am J Hematol; 2015 Apr; 90(4):295-300. PubMed ID: 25545153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effectiveness of vitamin D3 in patients with myelodysplastic syndromes, leukemias and myeloproliferative disorders].
    Takahashi T; Ichiba S; Okuno Y; Sugiyama H; Sakai Y; Imura H; Iho S; Hoshino T; Suzuki A; Okada T
    Rinsho Ketsueki; 1989 Jan; 30(1):1-10. PubMed ID: 2716194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
    Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
    Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1 alpha(OH)D3 (ETALPHA) treatment and receptor studies in 16 patients with chronic and myeloproliferative disorders.
    Wieslander SB; Mortensen BT; Binderup L; Nissen NI
    Eur J Haematol; 1987 Jul; 39(1):35-8. PubMed ID: 3477470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant molecules of interest in myeloproliferative neoplasms: introduction.
    Tefferi A
    Acta Haematol; 2008; 119(4):192-3. PubMed ID: 18566535
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of low-dose 1-hydroxyvitamin D3 in a patient with myelodysplasia after induction therapy for acute myelocytic leukemia.
    Fujisawa S; Motomura S; Sakai R; Tomita N; Fujimaki K; Mohri H; Okubo T
    Anticancer Drugs; 1997 Jun; 8(5):466-7. PubMed ID: 9215609
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of a patient with acute myeloid leukemia with 1 alpha(OH)D3.
    Nakayama S; Ishikawa T; Yabe H; Nagai K; Kasakura S; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1988 Sep; 51(6):1026-30. PubMed ID: 3201896
    [No Abstract]   [Full Text] [Related]  

  • 10. [Application of novel tyrosine-kinase inhibitors for the treatment of leukemia and Ph-negative myeloproliferative neoplasms].
    Kirito K
    Rinsho Ketsueki; 2011 Jul; 52(7):460-8. PubMed ID: 21821977
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of myelodysplastic syndrome with alfacalcidol].
    Tagawa M; Ito H; Kuriyama K; Tomonaga M; Ichimaru M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3160-2. PubMed ID: 3674901
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized study of alfacalcidol in the refractory myelodysplastic anaemias. A Japanese cooperative study.
    Yoshida Y; Oguma S; Uchino H; Maekawa T; Nomura T
    Int J Clin Pharmacol Res; 1993; 13(1):21-7. PubMed ID: 8509233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To treat or not to treat acute granulocytic leukemia.
    Crosby WH
    Arch Intern Med; 1968 Jul; 122(1):79-80. PubMed ID: 5241833
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of malignant hemopathies with aracytine in low doses. Analysis of 159 cases].
    Castaigne S; Tilly H; Sigaux F; Solal Celigny P; Bordessoule D; Brière J; Colombat P; Donadio D; Drony S; Guy H
    Nouv Rev Fr Hematol (1978); 1985; 27(6):377-82. PubMed ID: 3867852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
    Koh Y; Kim I; Bae JY; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Park MH; Park S; Kim BK
    Jpn J Clin Oncol; 2010 Nov; 40(11):1037-45. PubMed ID: 20587614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of allopurinol on 6-mercaptopurine therapy in neoplastic diseases.
    Rundles RW
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):655-6. PubMed ID: 5226511
    [No Abstract]   [Full Text] [Related]  

  • 17. [Successful alfacalcidol treatment of a patient with hypoplastic leukemia].
    Takahashi T; Ninomiya H; Hirama T; Hayashida W; Ichiba S; Okuno Y; Sugiyama H; Imura H; Nakamura K; Iho S
    Rinsho Ketsueki; 1986 Dec; 27(12):2361-5. PubMed ID: 3573325
    [No Abstract]   [Full Text] [Related]  

  • 18. Epigenetically centered evolution in an example of myeloid malignancy.
    Adélaide J; Cervera N; Carbuccia N; Garnier S; Guille A; Mozziconnaci MJ; Devillier R; Chaffanet M; Vey N; Birnbaum D; Gelsi-Boyer V
    Am J Hematol; 2016 Sep; 91(9):E361-2. PubMed ID: 27299509
    [No Abstract]   [Full Text] [Related]  

  • 19. NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.
    Forghieri F; Paolini A; Morselli M; Bigliardi S; Bonacorsi G; Leonardi G; Coluccio V; Maccaferri M; Fantuzzi V; Faglioni L; Colaci E; Soci F; Nasillo V; Messerotti A; Arletti L; Pioli V; Zucchini P; Quadrelli C; Corradini G; Giacobbi F; Vallerini D; Riva G; Barozzi P; Lagreca I; Marasca R; Narni F; Mecucci C; Ottaviani E; Martinelli G; Falini B; Luppi M; Potenza L
    Leuk Lymphoma; 2015; 56(11):3222-6. PubMed ID: 25813079
    [No Abstract]   [Full Text] [Related]  

  • 20. [Meningeal leukemia during blast crisis in a chronic myeloproliferative syndrome].
    Gabryś K; Kuliczkowski K
    Wiad Lek; 1981 Feb; 34(3):245-9. PubMed ID: 6942592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.